ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 266763 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 266763; 2) Community: the network communities that were significantly associated with the response to NSC 266763; 3) Molecule: the relationships between components within communities and NSC 266763; 4) MDR: the compounds that were significantly associated with the NSC 266763.

NSC Compound Enrichment Correlation
NSC 699471 Null 0.0386895225700413 -0.06132515
NSC 706192 Null 0.0386895225700413 0.14147389
NSC 720248 Null 0.0386895225700413 0.049961464
NSC 725191 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol 0.0386895225700413 -0.026788262
NSC 733906 Null 0.0386895225700413 0.10283384
NSC 736164 pyrazoline derivative 0.0386895225700413 0.32196189
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0386895225700413 0.065968787
NSC 133115 1-(.beta.-D-Ribofuranosyl)-4-amino-2-pyridone 0.0401206532535666 -0.067853168
NSC 14050 Delagil 0.0401206532535666 -0.044091733
NSC 674092 Quinoline-4-carboxamide, N,N'-[(1,4-piperazinediyl) bis(3,1-propanediyl)]bis(2-phenyl-, dihydrochloride 0.040120653253567 -0.1014377
Total:19  Current:13    [First] [Prev] [Next] [Last]